Compare III & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | III | PROF |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.4M | 230.4M |
| IPO Year | 2007 | N/A |
| Metric | III | PROF |
|---|---|---|
| Price | $5.91 | $8.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $12.00 |
| AVG Volume (30 Days) | 253.9K | ★ 288.0K |
| Earning Date | 03-05-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $241,289,000.00 | $14,297,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | $3.63 | $113.06 |
| P/E Ratio | $30.96 | ★ N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $2.95 | $3.76 |
| 52 Week High | $6.45 | $8.95 |
| Indicator | III | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 57.22 |
| Support Level | $5.79 | $7.45 |
| Resistance Level | $6.03 | $8.95 |
| Average True Range (ATR) | 0.21 | 0.58 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 60.24 | 61.13 |
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.